Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s stock price rose 6.2% during mid-day trading on Thursday . The company traded as high as $11.19 and last traded at $11.11. Approximately 944,199 shares traded hands during mid-day trading, an increase of 179% from the average daily volume of 337,931 shares. The stock had previously closed at $10.46.
Silverback Therapeutics Trading Up 2.2 %
The stock has a market cap of $409.26 million, a P/E ratio of -4.69 and a beta of 0.60. The firm’s fifty day moving average is $8.92 and its 200 day moving average is $8.15.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- How to Use the MarketBeat Stock Screener
- MarketBeat Week in Review – 7/8 – 7/12
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
